PHÂN TÍCH THỰC TRẠNG CHỈ ĐỊNH THUỐC ĐIỀU TRỊ TĂNG HUYẾT ÁP TẠI KHOA NỘI TIM MẠCH BỆNH VIỆN HỮU NGHỊ VIỆT XÔ

Abstract

Background: Hypertension (THA) is the leading cause of death and cardiovascular disease. Choosing the right antihypertensive drug according to treatment guidelines not only helps to control blood pressure well, but also reduces the cost of treatment and other medical services. The aim of this study is analyzing the appropriateness of antihypertensive drug use in terms of protocol and cost. Materials and methods: Medical record of inpatients at the Cardiovascular Departmen of the Huu Nghi Viet Xo Hospital , using cross-sectional descriptive methods. Results: The rate of using multi therapy regimens is higher than that of monotherapy. The proportion of HSBA indicated in the fixed dose multi-treatment regimen (FDC) is 15.9%. Average cost of antihypertensive drugs in FDC regimen was highest. According to the guidelines of the Vietnam Heart Association (VNHA) 2018, comorbidities are indicated with appropriate regimen accounting for a high proportion such as diabetes, kidney failure, stroke. 38,2% of medical record changed drug designation. Factors affecting the cost of antihypertensive drugs include: level of hypertension, number of comorbidities, changes in drug indications, treatment regimen, and number of days treatment. Conclusion: Most of the indications for hypertension treatment regimens in the study sample are consistent with the guidelines of VNHA 2018. Days of treatment and treatment regimen are the two factors that most affect the cost of antihypertensive drug.